Cargando…

Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis

Detalles Bibliográficos
Autores principales: Xu, Yan, Song, Yanjun, Liu, Xiaoyan, Shi, Yuequan, Liu, Yingxian, Qian, Hao, Gao, Xiaoxing, Chen, Minjiang, Pan, Ruili, Zhao, Jing, Zhong, Wei, Wu, Wei, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456696/
https://www.ncbi.nlm.nih.gov/pubmed/35678260
http://dx.doi.org/10.1002/cac2.12320
_version_ 1784785881015517184
author Xu, Yan
Song, Yanjun
Liu, Xiaoyan
Shi, Yuequan
Liu, Yingxian
Qian, Hao
Gao, Xiaoxing
Chen, Minjiang
Pan, Ruili
Zhao, Jing
Zhong, Wei
Wu, Wei
Wang, Mengzhao
author_facet Xu, Yan
Song, Yanjun
Liu, Xiaoyan
Shi, Yuequan
Liu, Yingxian
Qian, Hao
Gao, Xiaoxing
Chen, Minjiang
Pan, Ruili
Zhao, Jing
Zhong, Wei
Wu, Wei
Wang, Mengzhao
author_sort Xu, Yan
collection PubMed
description
format Online
Article
Text
id pubmed-9456696
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94566962022-09-12 Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis Xu, Yan Song, Yanjun Liu, Xiaoyan Shi, Yuequan Liu, Yingxian Qian, Hao Gao, Xiaoxing Chen, Minjiang Pan, Ruili Zhao, Jing Zhong, Wei Wu, Wei Wang, Mengzhao Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2022-06-09 /pmc/articles/PMC9456696/ /pubmed/35678260 http://dx.doi.org/10.1002/cac2.12320 Text en © 2022 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters to the Editor
Xu, Yan
Song, Yanjun
Liu, Xiaoyan
Shi, Yuequan
Liu, Yingxian
Qian, Hao
Gao, Xiaoxing
Chen, Minjiang
Pan, Ruili
Zhao, Jing
Zhong, Wei
Wu, Wei
Wang, Mengzhao
Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis
title Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis
title_full Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis
title_fullStr Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis
title_full_unstemmed Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis
title_short Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis
title_sort prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456696/
https://www.ncbi.nlm.nih.gov/pubmed/35678260
http://dx.doi.org/10.1002/cac2.12320
work_keys_str_mv AT xuyan predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT songyanjun predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT liuxiaoyan predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT shiyuequan predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT liuyingxian predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT qianhao predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT gaoxiaoxing predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT chenminjiang predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT panruili predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT zhaojing predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT zhongwei predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT wuwei predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis
AT wangmengzhao predictionofmajoradversecardiaceventsisthefirstcriticaltaskinthemanagementofimmunecheckpointinhibitorassociatedmyocarditis